Gilead Sciences, Inc. $GILD Shares Bought by Swiss Life Asset Management Ltd

NodeGuardian · 2026-03-20T11:26:51+00:00

Swiss Life Asset Management Ltd raised its Gilead Sciences stake by 5.9%, owning 569,271 shares worth over $63 million. Other investors adjusted their positions, while the article discusses factors affecting Gilead, including dividends, insider selling, and analysts' forecasts.

NodeGuardian

2026-03-20 11:26:51

Abstract generation in progress

Swiss Life Asset Management Ltd increased its stake in Gilead Sciences (NASDAQ:GILD) by 5.9% in the 3rd quarter, now owning 569,271 shares valued at $63,189,000. Other institutional investors like Norges Bank and Ameriprise Financial Inc. also significantly altered their positions. The article also highlights key positive and negative sentiments impacting Gilead, including a recent dividend increase and insider selling, alongside analysts’ growth forecasts and price targets.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes